These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 7724603)

  • 21. [The role of apolipoprotein E in the pathogenesis of Alzheimer disease].
    Okuizumi K
    Nihon Rinsho; 1999 Dec; 57(12):2673-7. PubMed ID: 10638195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease.
    Harrington CR; Louwagie J; Rossau R; Vanmechelen E; Perry RH; Perry EK; Xuereb JH; Roth M; Wischik CM
    Am J Pathol; 1994 Dec; 145(6):1472-84. PubMed ID: 7992850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Apolipoprotein E gene polymorphisms and Alzheimer disease].
    Chen D; Zhang JW; Zhang ZX; Zhao HL; Li XQ; Wu YN; Qu QM
    Yi Chuan Xue Bao; 2003 Dec; 30(12):1167-70. PubMed ID: 14986436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive value of apolipoprotein E genotyping in Alzheimer's disease: results of an autopsy series and an analysis of several combined studies.
    Nalbantoglu J; Gilfix BM; Bertrand P; Robitaille Y; Gauthier S; Rosenblatt DS; Poirier J
    Ann Neurol; 1994 Dec; 36(6):889-95. PubMed ID: 7998776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein E4 and beta amyloid in senile plaques and cerebral blood vessels of aged rhesus monkeys.
    Poduri A; Gearing M; Rebeck GW; Mirra SS; Tigges J; Hyman BT
    Am J Pathol; 1994 Jun; 144(6):1183-7. PubMed ID: 8203459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of the apolipoprotein E epsilon 4 allele with clinical subtypes of autopsy-confirmed Alzheimer's disease.
    Zubenko GS; Stiffler S; Stabler S; Kopp U; Hughes HB; Cohen BM; Moossy J
    Am J Med Genet; 1994 Sep; 54(3):199-205. PubMed ID: 7810577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
    Susanto TA; Pua EP; Zhou J;
    J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and neuropathological correlates of apolipoprotein E genotype in dementia with Lewy bodies.
    Singleton AB; Wharton A; O'Brien KK; Walker MP; McKeith IG; Ballard CG; O'Brien J; Perry RH; Ince PG; Edwardson JA; Morris CM
    Dement Geriatr Cogn Disord; 2002; 14(4):167-75. PubMed ID: 12411758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regional variation in the distribution of apolipoprotein E and A beta in Alzheimer's disease.
    Gearing M; Schneider JA; Robbins RS; Hollister RD; Mori H; Games D; Hyman BT; Mirra SS
    J Neuropathol Exp Neurol; 1995 Nov; 54(6):833-41. PubMed ID: 7595656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age.
    Kok E; Haikonen S; Luoto T; Huhtala H; Goebeler S; Haapasalo H; Karhunen PJ
    Ann Neurol; 2009 Jun; 65(6):650-7. PubMed ID: 19557866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case-control study of apolipoprotein E genotypes in Alzheimer's disease associated with Down's syndrome. Dutch Study Group on Down's Syndrome and Ageing.
    van Gool WA; Evenhuis HM; van Duijn CM
    Ann Neurol; 1995 Aug; 38(2):225-30. PubMed ID: 7654070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein.
    Polvikoski T; Sulkava R; Haltia M; Kainulainen K; Vuorio A; Verkkoniemi A; Niinistö L; Halonen P; Kontula K
    N Engl J Med; 1995 Nov; 333(19):1242-7. PubMed ID: 7566000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution.
    Hyman BT; Marzloff K; Arriagada PV
    J Neuropathol Exp Neurol; 1993 Nov; 52(6):594-600. PubMed ID: 8229078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between APOE genotype, neuropathology and dementia in the older population of England and Wales.
    Nicoll JA; Savva GM; Stewart J; Matthews FE; Brayne C; Ince P;
    Neuropathol Appl Neurobiol; 2011 Apr; 37(3):285-94. PubMed ID: 20880354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropathology and apolipoprotein E profile of aged chimpanzees: implications for Alzheimer disease.
    Gearing M; Rebeck GW; Hyman BT; Tigges J; Mirra SS
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9382-6. PubMed ID: 7937774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.
    Strittmatter WJ; Saunders AM; Schmechel D; Pericak-Vance M; Enghild J; Salvesen GS; Roses AD
    Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1977-81. PubMed ID: 8446617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct distribution of apolipoprotein E and beta-amyloid immunoreactivity in the hippocampus of Parkinson dementia complex of Guam.
    Schwab C; Steele JC; Akiyama H; McGeer PL
    Acta Neuropathol; 1996 Oct; 92(4):378-85. PubMed ID: 8891070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy.
    Attems J; Jellinger KA; Lintner F
    Acta Neuropathol; 2005 Sep; 110(3):222-31. PubMed ID: 16133541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The apolipoprotein E genotype and Down's syndrome].
    Rascón Trincado MV; González Sarmiento R; Salazar A-Villalobos V
    Rev Clin Esp; 1997 Oct; 197(10):680-3. PubMed ID: 9424665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.